Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses – IVY Network, September 1, 2022-March 30, 2023

By sjmartinez • November 14, 2024

Lewis NM, Harker EJ, Leis A, Zhu Y, Talbot HK, Grijalva CG, Halasa N, Chappell JD, Johnson CA, Rice TW, Casey JD, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, DeCuir J, Surie D, Dawood FS, Ellington S, Self WH, Martin ET. Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023. Vaccine. 2024 Nov 7;43(Pt 2):126492. doi: 10.1016/j.vaccine.2024.126492. Epub ahead of print. PMID: 39515195.

Tags: bias, covid-19, Estimation, Influenza, Publications, Pulmonary, Critical Care & Sleep Medicine, RSV, vaccine effectiveness

Differences Among Veterans With Chronic Overlapping Pain Conditions and Other Chronic Pain: Baseline Results From the LAMP Pain Management Trial

Adamowicz JL, Grant A, Calvert C, Elchert D, Hadlandsmyth K, Driscoll MA, Taylor SL, Allen K, Taylor BC, Burgess DJ. Differences Among Veterans With Chronic[...]

Risk of Cutaneous T-cell Lymphoma in Patients with Autoimmune Diseases

Brumbaugh B, Westmeijer M, Thompson B, Holt A, Ebriani J, Sheng-Kai Ma K, Chen ST. Risk of Cutaneous T-cell Lymphoma in Patients with Autoimmune Diseases.[...]

SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis

Herrmann K, Walz J, MacLennan S, Briganti A, Cornford P, Czernin J, Eiber M, Fanti S, Fendler WP, Fizazi K, Gafita A, Gillessen S, Goffin[...]